60
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data

, , &
Pages 831-838 | Published online: 27 Apr 2017

Figures & data

Figure 1 CONSORT diagram showing patient selection for primary and secondary objectives.

Notes: aCystic Fibrosis ICD-9-CM: 277.0x, ICD-10-CM: E84.x. bEnrollment gap allowance of 45 days applied.
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; TIP, tobramycin inhalation powder; TIS, tobramycin inhalation solution.
Figure 1 CONSORT diagram showing patient selection for primary and secondary objectives.

Table 1 Summary of patient demographic characteristics

Table 2 Summary of patient clinical characteristics

Table 3 Multivariable analysis of adherence to tobramycin inhalation powder relative to tobramycin inhalation solution (high vs low/medium utilization)